#generic drugs

[ follow ]
#generic-drugs #mifepristone #fda-approval #drug-pricing #fda #abortion-policy #abortion-politics
Intellectual property law
fromPatently-O
3 days ago

Label-Plus Liability: The Government Warns the Federal Circuit Misread Hatch-Waxman

The Solicitor General urges Supreme Court review to clarify that FDA-compliant skinny labels and basic commercial statements should not automatically constitute inducement of patent infringement.
fromLos Angeles Times
1 month ago

Cheap insulin pens will soon be available through state-backed deal, Newsom announces

ration insulin or go into debt to stay alive.
California
US politics
fromMedCity News
2 months ago

FDA Pilot Program Creates New Path for Faster Regulatory Review of Generic Drugs - MedCity News

FDA pilot program speeds regulatory review for generic drugs that use domestic APIs and are tested and manufactured entirely within the United States.
#mifepristone
more#mifepristone
Public health
fromFortune
2 months ago

Gates Foundation partners with Indian drugmakers to speed rollout of $40 HIV shot | Fortune

Generic lenacapavir at about $40 per patient annually will expand access to six-month HIV prevention injections for millions worldwide.
fromwww.aljazeera.com
3 months ago

WHO adds weight-loss, diabetes drugs to essential medicines list

The list, consisting of 523 medicines for adults and 374 for children, is a catalogue of the drugs the WHO believes should be available in all functioning health systems. The new editions of essential medicines lists mark a significant step toward expanding access to new medicines with proven clinical benefits and with high potential for global public health impact, said Yukiko Nakatani, WHO's assistant director-general for Health Systems, Access and Data.
Public health
Law
fromPatently-O
5 months ago

Corcept v. Teva Oral Argument: Infringement by Drug Label, Again

Federal Circuit's theory of infringement by drug label implicates generic drug companies for inducing infringement based on their product labels.
fromPatently-O
5 months ago

Label-Plus Infringement: The Tinderbox Theory of Generic Inducement

Hikma's generic Vascepa, with its "skinny label," poses a challenge for patent protection, potentially undermining the incentives for innovation in the pharmaceutical industry.
Intellectual property law
Intellectual property law
fromIPWatchdog.com | Patents & Intellectual Property Law
6 months ago

FTC Renews Campaign to Remove 'Junk' Inhaler and Device Patents from Orange Book Listings

FTC's warning letters may lead to extended litigation over patent listings.
The agency aims to improve access to generic drugs by challenging patents.
Targeted patents in the pharmaceutical sector are under scrutiny.
Efforts continue irrespective of longstanding industry calls for clearer guidelines.
US politics
fromTruthout
7 months ago

Tariffs on Pharmaceuticals May Be the Next Front in Trump's War on Public Health

Trump's proposed tariffs on pharmaceuticals could lead to higher costs and shortages of medications for U.S. patients.
[ Load more ]